Parkinson's Disease Trial, Recruiting NCT04720365 Sponsor: University Hospital, Rouen Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT04720365
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with idiopathic Parkinson's disease (a specific type of Parkinson's confirmed using standard medical guidelines)
  • You are 18 years of age or older
  • You have walking and/or balance problems that have not improved with levodopa (a common Parkinson's medication), as measured by a standard assessment tool (confirm with trial site)
  • You have fallen 2 or more times in the past year
  • Your Parkinson's medications have not changed for at least 1 month before joining the study
  • You have social health insurance coverage
  • You are willing and able to give your informed, voluntary consent to take part in the study
  • Any other health conditions you have are stable and would not interfere with the study

Who may not be able to join:

  • Your Parkinson's disease is at the most advanced stage, meaning you are unable to stand or walk on your own
  • You have dementia, as measured by standard memory and thinking tests (confirm with trial site)
  • You have issues with impulse control, as identified by a standard Parkinson's assessment (confirm with trial site)
  • You do not have an internet connection at home
  • You have a serious health condition that would interfere with the study activities
  • Your life expectancy is estimated to be less than 2 years
  • You are currently not allowed to take part in other research studies
  • You are under guardianship or any legal measure that limits your rights or freedom
  • You are pregnant, or you are a woman who could become pregnant and are not using contraception

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marie-Laure WELTER, Professor, Rouen Uiniversity Hospital

Phone: (33) 02 32 88 82 65

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Rouen
Registry
ClinicalTrials.gov
Start date
15 February 2023
Est. completion
1 February 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

The incremental cost-utility ratio at 12 months for the management of patients with Parkinson's disease using therapeutic games

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov